Fibrinolytic system and reproductive process with special reference to fibrinolytic failure in pre-eclampsia

被引:25
作者
Gilabert, J
Estelles, A
Grancha, S
Espana, F
Aznar, J
机构
[1] LA FE UNIV HOSP, RES CTR, VALENCIA, SPAIN
[2] LA FE UNIV HOSP, DEPT CLIN PATHOL, VALENCIA, SPAIN
关键词
fibrinolysis; placenta; plasminogen activator inhibitors; pre-eclampsia; pregnancy; reproduction;
D O I
10.1093/humrep/10.suppl_2.121
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Here we summarize the recent progress in research on the role of the fibrinolytic system in reproduction, with a special emphasis on the role of the plasminogen activator inhibitors in fetal development, Trophoblasts produce fibrinolytic proteins that can promote normal implantation and regulate blood dow to the fetus and placenta throughout pregnancy, Normal pregnancy is associated with a hypofibrinolytic state that is fundamentally caused by an increase in plasminogen activator inhibitors types 1 and 2. In pre-eclampsia, a fibrinolytic failure, resulting from an increase in plasma and placental concentrations of plasminogen activator inhibitor-1, was observed, The localized elevated concentrations of placenta plasminogen activator inhibitor-1 protein and mRNA observed in pre-eclamptic patients would be expected to foster the deposition of fibrin and thus play a role in the complications associated with this disease. The decreased plasminogen activator inhibitor-2 concentrations in placenta and plasma from intrauterine fetal growth retardation pregnancies and the positive correlation between plasma/placenta plasminogen activator inhibitor-2 concentration and birthweight suggest that this inhibitor could be considered an adequate marker of placental function.
引用
收藏
页码:121 / 131
页数:11
相关论文
共 67 条
[51]  
NY T, 1994, FIBRINOLYTIC INHIBIT, P32
[52]  
PENG XR, 1992, FIBRINOLYSIS, V6, P151
[53]   PLACENTAL BED SPIRAL ARTERIES IN THE HYPERTENSIVE DISORDERS OF PREGNANCY [J].
PIJNENBORG, R ;
ANTHONY, J ;
DAVEY, DA ;
REES, A ;
TILTMAN, A ;
VERCRUYSSE, L ;
VANASSCHE, A .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1991, 98 (07) :648-655
[54]  
PRITCHARD JA, 1980, WILLIAMS OBSTETRICS, P665
[55]  
QUEENAN JT, 1987, J BIOL CHEM, V262, P10903
[56]   TISSUE-TYPE PLASMINOGEN-ACTIVATOR AS A MARKER FOR FUNCTIONAL ZONES, WITHIN THE HUMAN-PROSTATE GLAND [J].
REESE, JH ;
MCNEAL, JE ;
REDWINE, EA ;
STAMEY, TA ;
FREIHA, FS .
PROSTATE, 1988, 12 (01) :47-53
[57]   PLASMINOGEN-ACTIVATOR INHIBITORS (PAI-1 AND PAI-2) IN NORMAL PREGNANCIES, PREECLAMPSIA AND HYDATIDIFORM MOLE [J].
REITH, A ;
BOOTH, NA ;
MOORE, NR ;
CRUICKSHANK, DJ ;
BENNETT, B .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (04) :370-374
[58]  
RIJKEN DC, 1990, THROMB RES, P63
[59]   PLASMINOGEN ACTIVATORS IN TISSUE REMODELING AND INVASION - MESSENGER-RNA LOCALIZATION IN MOUSE OVARIES AND IMPLANTING EMBRYOS [J].
SAPPINO, AP ;
HUARTE, J ;
BELIN, D ;
VASSALLI, JD .
JOURNAL OF CELL BIOLOGY, 1989, 109 (05) :2471-2479
[60]   AN ULTRASTRUCTURAL-STUDY OF UTEROPLACENTAL SPIRAL ARTERIES IN HYPERTENSIVE AND NORMOTENSIVE PREGNANCY AND FETAL GROWTH-RETARDATION [J].
SHEPPARD, BL ;
BONNAR, J .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1981, 88 (07) :695-705